Abstract
Human neutrophils (PMNs) which have been incubated with lipoteichoic acid (LTA) from group A streptococci generated large amounts of Superoxide (O −2 chemiluminescence and hydrogen peroxide when challenged with anti-LTA antibodies. Cytochalasin B further enhanced O *2 generation. The onset of Of generation by the LTA-anti-LTA complexes was much faster than that induced by BSA-anti-BSA complexes. LTA-treated PMNs generated much less O *2 when challenged with BSA complexes, suggesting that LTA might have blocked, nonspecifically, some of the Fc receptors on PMNs. PMNs treated with LTA-anti-LTA complexes further interacted with bystander nonsensitized PMNs resulting in enhanced Of generation, suggesting that small numbers of LTA-sensitized PMNs might recruit additional PMNs to participate in the generation of toxic oxygen species. Protelolytic enzyme treatment of PMNs further enhanced the generation of O −2 by PMNs treated with LTA-anti-LTA. Superoxide generation could also be induced when PMNs and anti-LTA antibodies interacted with target cells (fibroblasts, epithelial cells) pretreated with LTA. This effect was also further enhanced by pretreatment of the target cells with proteases. PMNs incubated with LTA released lysosomal enzymes following treatment with anti-LTA antibodies. The amounts of phosphatase,Β-glucoronidase,N-acetylglucosaminidase, mannosidase, and lysozyme release by LTA-anti-LTA complexes were much smaller than those released by antibody or histone-opsonized streptococci, suggesting that opsonized particles are more efficient lysosomal enzyme releasers. However, since the amounts of O −2 generated by the LTA complexes equaled those generated by the opsonized particles, it is assumed that the signals for triggering a respiratory burst and lysosomal enzyme secretion might be different.
Similar content being viewed by others
References
Wicken, A. J., and K. W.Knox. Lipoteichoic acids: A new class of bacterial antigen.Science 187:1161–1167.
Shockman, G. D., andA. J. Wicken. 1981. Chemistry and Biological Activities of Bacterial Surface Amphiphiles. Academic Press, New York.
Huff, E. 1981. Lipoteichoic acid, a major amphiphile of Gram-positive bacteria that is not readily extractable.J. Bacteriol. 149:399–402.
Harris, T. N., andS. Harris. 1953. Agglutination by human sera of erythrocytes incubated with streptococcal culture supernates.J. Bacteriol. 66:159–165.
Neter, E. 1956. Bacterial hemagglutinization and hemolysis.Bacteriol. Rev. 20:166–188.
Stewart, F. S., andW. T. Martin. 1962. Absorption of streptococcal red cell sensitizing antigen to various tissues.J. Pathol. Bacteriol. 84:251–253.
Jackson, R. W., andM. Moskowitz. 1966. Nature of red cell sensitizing substance from streptococci.J. Bacteriol. 91:2205–2209.
Moskowitz, M. 1966. Separation and properties of a red-cell-sensitizing substance from streptococci.J. Bacteriol. 91:2200–2204.
Neeman, N., andI. Ginsburg. 1972. Red cell sensitizing antigen of group streptococci. I. Biological and chemical properties.Isr. J. Med. 8:1799–1806.
Sela, M. N., M. Lahva, andI. Ginsburg. 1977. Effect of leukocyte hydrolase on bacteria. IX. The release of lipoteichoic acid from group A streptococci and fromStreptococcus mutons by leukocyte extracts by lysozyme: Relation to tissue damage in inflammatory sites.Inflammation 2:151–164.
Horne, D., andA. Tomasz. 1979. Release of lipoteichoic acid fromStreptococcus sanguis. Stimulation of release during penicillin treatment.J. Bacteriol. 137:1180–1184.
Nealon, M. J., E. H. Beachey, H. S. Courtney, andA. Simpson. 1986. Release of fibronectin-lipoteichoic acid complexes from group a streptococci with penicillin.Infect. Immun. 51:529–535.
Knox, K. W., andA. J. Wicken. 1975. Immunological properties of teichoic acids.Bacteriol. Rev. 37:215–257.
Ofek, I., E. H. Beachey, W. Jefferson, andG. L. Campbell. 1975. Cell membrane binding properties of group A streptococcal lipoteichoic acid.J. Exp. Med. 141:990–1003.
Beachey, E. H., andI. Ofek. 1976. Epithelial cell binding on group A streptococcal by lipoteichoic acid on fimbriae of denuded M protein.J. Exp. Med. 143:759–771.
Beachey, W. H., T. M. Chiang, I. Ofek, andA. H. Kang. 1977. Interaction of lipoteichoic acid with human platelets.Infect. Immun. 16:649–654.
Courtney, H., I. Ofek, A. Simpson, andE. H. Beachey. 1981. Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood.Infect. Immun. 32:625–631.
Courtney, H. S., A. W. Simpson, andE. H. Beachey. 1986. Relationship of critical micelle concentrations of bacterial lipoteichoic acid to biological activities.Infect. Immun. 51:414–418.
Dishon, T., R. Finkel, Z. Marcus, andI. Ginsburg. 1967. Cell sensitizing products of streptococi.Immunology 13:555–564.
Neeman, N., andI. Ginsburg. 1971. Red cell sensitizing agent of group A streptococci. II. Immunological and immunopathological properties.Isr. J. Med. Sci. 8:1807–1816.
Ferne, M., S. Bergner-Rabinowitz, andI. Ginsburg. 1976. The effect of leukocyte hydrolases on bacteria. IV. The role played by leukocyte extracts in the sensitization of RBC by lipopolysaccharides and the cell-sentitizing factor of group A streptococci.Inflammation 1:247–260.
Hummel, S. D., andJ. A. Winkelstein. 1986. Bacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement.J. Clin. Invest. 77:1533–1538.
B. D. Weinreb, G. D. Shockman, S. E. Beachey, A. J. Swift, andJ. A. Winkelstein. 1986. The ability of sensitized host cells for destruction by autologous complement is a general property of lipoteichoic acid.Infect. Immun. 54:797–799.
Simpson, W. A., J. B. Dale, andE. H. Beachey. 1982. Cytotoxicity of the glycolipid region of stretococcal lipoteichoic acid for cultures of human heart cells.J. Lab. Clin. Med. 99:118–126.
Leon, O., andC. Panos. 1983. Cytotoxicity and inhibition of normal collagen synthesis in mouse fibroblasts by lipoteichoic acid ofStreptococcus pyogenes type 12.Infect. Immun. 40:758–794.
Loos, M., F. Clas, andW. Fischer. 1986. Interaction of purified lipoteichoic acid with the classical complement pathway.Infect. Immun. 53:595–599.
Winkelstein, J. A., andA. Tomasz. 1978. Activation of the alternative complement pathway for pneumococcal cell wall teichoic acid.J. Immunol. 120:174–178.
Hadrop, P. J., R. L. Grady, K. W. Knox, andA. J. Wicken. 1980. Stimulation of lysosomal enzyme release macrophages by lipoteichoic acid.J. Periodont. Res. 15:492–501.
Ginsburg, I., andP. G. Quie. 1980. Modulation of human polymorphonuclear chemotaxis by leukocyte extracts, bacterial products, inflammatory exudates and polyelectrolytes.Inflammation 4:310–311.
Raynor, R. H., D. F. Scott, andG. K. Best. 1981. Lipoteichoic acid inhibition of phagocytosis ofStaphylococcus aureus by human polymorphonuclear leukocytes.Clin. Immunol. Immunopathol. 19:181–189.
Sela, M. N., I. Ginsburg, T. Dishon, Z. Duchan, andA. A. Garfunkel. 1982. Modulation of human lymphocyte transformation by bacterial products and leukocyte lysates.Inflammation 6:31–38.
Aasjord, P., H. Nyland, andR. Marte. 1986. The mitogenic properties of lipoteichoic acid fromStaphylococcus aureus.Acta Pathol. Microbiol. Immunol. Scand. Sect. C 94:91–96.
Miller, G. A., andR. W. Jackson. 1973. Effect of a streptococcus pyogen teichoic acid on the immune response of mice.J. Immunol. 110:148–156.
Hausman, E., O. Luderitz, K. W. Knox, andN. W. Weinfeld. 1975. Structural requirements for bone resorption by endotoxin and lipoteichoic acid.J. Dent. Res. 54:94–99.
Bab, I., M. N. Sela, I. Ginsburg, andT. Dishon. 1979. Inflammatory lesion and bone resorption induced in rat periodontium by lipoteichoic acid.Inflammation 3:345–358.
Aasjord, P., H. Nyland, andS. Mork. 1980. Encephalitis in rabbits by lipoteichoic acid.Acta Pathol. Microbiol. Scand. Sect. C 88:287–291.
Fiedel, L. A., andR. W. Jackson. 1979. Nephropathy in the rabbit associated with immunization to group A streptococcal lipoteichoic acid.Med. Microbiol. Immunol. 167:251–260.
Lopatin, D., andR. E. Kessler. 1985. Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic antibodies.Infect. Immun. 48:638–643.
Yamammoto, A., H. Usami, M. Nagamuta, Y. Sugawara, S. Hamada, T. Yamamoto, K. Kato, S. Kokeguchi, andS. Kotami. 1985. The use of lipoteichoic acid (LTA) from streptococcus pyogen to induce a serum factor causing tumor necrosis.Br. J. Cancer 51:739–742.
Leon, O., andC. Panos. 1985. Effect of streptococcal lipoteichoic acid on prolyl hydroxylase activity as related to collagen formation in mouse fibroblasts.Infect. Immun. 50:641–646.
Holtje, J. V., andA. Tomasz. 1975. Lipoteichoic acid: A specific inhibitor of autolysin activity in pneumococci.Proc. Natl. Acad. Sci. U.S.A. 72:1690–1691.
Cleveland, R. F., A. J. Wicken, L. Daneo-Moore, andG. D. Shockman. 1976. Inhibition of wall autolysis inStreptococcus faecalis by lipoteichoic acid.J. Bacteriol. 126:192–197.
Sela, M. N., I. Ofek, M. Lahav, andI. Ginsburg. 1978. The effect of leukocyte hydrolases on bacteria. XI. Lysis by leukocyte extracts and myeloperoxidase ofStaphylococcus aureus mutant which is deficient in teichoic acid and the initiation of bacteriolysis by lipoteichoic acid.Proc. Soc. Exp. Biol. Med. 159:126–130.
Tomasz, A., andS. Waks. 1975. Mechanism of action of penicillin: Triggering of pneumococcal autolytic enzyme by inhibitors of cell-wall synthesis.Proc. Natl. Acad. Sci. U.S.A. 72:4162–4166.
Tomasz, A. 1979. The mechanisms of irreversible anti-microbial effect of penicillin: How the beta lactam antibiotics kill and lyse bacteria.Annu. Rev. Microbiol. 33:113–137.
Weiss, S. J., andP. A. Ward. 1982. Immune complex induced generation of oxygen metabolites of human neutrophils.J. Immunol. 129:309–313.
Fischer, W., H. V. Kach, andP. Haas. 1983. Improved preparation of lipoteichoic acids.Eur. J. Biochem. 154(3):1115–1116.
Ginsburg, I. 1972. Mechanisms of cell and tissue injury induced by group A streptococci: Relation to poststreptococcal sequelae.J. Infect. Dis. 120:294–315.
Ginsburg, I., R. Borinski, D. Malamud, F. Struckmeire, andV. Klimetzek. 1985. Chemiluminescence and Superoxide generation by leukocytes stimulated by polyelectrolyte-opsonized polyhistidine, cytochalasins and inflammatory exudates as modulators of oxyen burst.Inflammation 9:245–271.
Babior, B., J. T. Curnutte, andB. McMurrich. 1976. The particulate superoxide forming system from human neutrophils: Properties of the system and further evidence supporting its participation in the respiratory burst.J. Clin. Invest. 58:989–996.
Thurman, R. G., H. G. Leyland, andR. Scholz. 1972. Hepatic microsomal ethanol oxidation, hydrogen peroxide formation and the role of catalase.Eur. J. Biochem. 25:420–430.
Ginsburg, I., R. Borinski, M. Sadovnic, Y. Eilam, andK. Rainsford. 1987. Poly-l-histidine: A potent stimulator of superoxide generation in human blood leukocytes.Inflammation 11:253–277.
McPhail, L. C., P. Henson, andR. B. Johnston. 1981. Respiratory burst enzyme in human neutrophil: Evidence for multiple mechanisms of activation.J. Clin Invest. 67:710–716.
Warren, J. S., P. A. Ward, K. J. Johnson, andI. Ginsburg. 1987. Modulation of acute immune complex-mediated tissue injury by the presence of polyionic substances.Am. J. Pathol. 128:67–77.
Ginsburg, I. 1987. Cationic polyelectrolytes: A new look at their possible roles as opsonins, as stimulators of the respiratory burst in leukocytes, in bacteriolysis and as modulators of immune complex disease.Inflammation 11:489–515.
Ginsburg, I., R. Borinski, M. Lahav, Y. Matzner, I. Eliasson, P. Christensen, andD. Malamud. 1984. Poly-l-arginine and N-formylated chemotactic peptide act synergistically with lectin and calcium inonophore to induce intense chemiluminescence and Superoxide production in human blood leukocytes: Modulation by metabolic inhibitors of sugars and polyelectrolytes.Inflammation 8:1–26.
Henricks, P. A., M. Van Der Tol, R. M. W. M. Thyssen, B. S. Van Asbeck, andJ. Ver-Hoef. 1983.Escherichia coli lipopolysacchride diminish and enhance cell function of human polymorphonuclear leukocytes.Infect. Immun. 4:294–301.
Kapp, A., M. Freudenberg, andC. Gallanos. 1987. Induction of human granulocyte chemiluminesence by bacterial lipopolysaccharides.Infect. Immun. 55:758–761.
Abramson, S., H. Edelson, H. Kaplan, W. Given, andG. Weissmann. 1984. The inactivation of the polymorphonuclear leukocyte by nonsteroidal antiinflammatory drugs.Inflammation 8:S103-S108.
Fantone, J. C., W. A. Marasco, L. J. Elgas, andP. Ward. 1984. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and Superoxide anion production.Am. J. Pathol. 115:9–16.
Ward, P. A., M. C. Sulavik, andK. J. Johnson. 1984. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.Am. J. Pathol. 116:223–233.
Sedgwick, J. B., M. L. Berube, andR. B. Zurier, 1985. Stimulus-dependent inhibition of superoxide generation by prostaglandins.Clin. Immunol. Immunopathol. 34:205–215.
Cohen, H. J., M. E. Chovaniec, andS. E. Ellis. 1980. Chloropromazin inhibition of granulocyte superoxide production.Blood 56:23–29.
Goldstein, I. M., M. Cerquerira, S. Lind, andH. Kaplan. 1977. Evidence that superoxide-generating system of human leukocytes is associated with the cell surface.J. Clin. Invest. 59:249–254.
Romeo, D., G. Sabucchi, andF. Rossi. 1973. Reversible metabolic stimulation of polymorphonuclear leukocytes and macrophages by concanavalin.Nature 243:111.
Hatch, G., D. E. Gardner, andD. B. Menzel. 1978. Chemiluminescence of phagocytic cells caused by N-formyl-methionyl peptide.J. Exp. Med. 147:182–195.
Becker, E. L., M. Sigman, andM. Oliver. 1979. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptide and A23187: The nature of receptor and the requirement of Ca++.Am. J. Pathol. 95:81–97.
Cohen, H. J., andM. E. Chovaniec. 1978. Superoxide generation by digitonin stimulated guinea-pig granulocytes. A basis for continuous assay for monitoring Superoxide production.J. Clin. Invest. 61:1081–1087.
Ginsburg, I., R. Borinski, andM. Pabst. 1985. NADPH and “cocktails” containing polyarginine reactivate Superoxide generation in leukocyte lysed by membrane-damaging agents.Inflammation 9:341–363.
Weiss, S. J., andP. Ward. 1982. Immune complex induced generation of oxygen metabolite by human neutrophils.J. Immunol. 129:309–313.
Malawista, S. E., J. B. L. Gee, andK. G. Bensch. 1971. Cytochalasin B reversibility inhibits phagocytosis: Functional, metabolic and structural effects in human blood leukocytes and rabbit alveolar macrophages.Yale J. Biol. Med. 44:286–300.
Elferink, J. G. R., andJ. C. Riemersma. 1981. The effect of cytochalasin on polymorphonuclear leukocytes activated by chemotactic peptide.J. Reticuloendothelial Soc. 29:163–174.
Wright, S. D., andS. D. Silverstein. 1983. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes.J. Exp. Med. 158:2016–2023.
Ginsburg, I., S. E. G. Fligiel, R. G. Kunkel, andJ. Varani. 1987. Phagocytosis ofCandida albicans enhance malignant behavior of murine tumor cells.Science 238:1573–1575.
Author information
Authors and Affiliations
Additional information
Supported by a research grant from Dr. S. M. Robbins of Cleveland Ohio, and by grants HL-288442, HL-31963 and GM-29507, from the National Institutes of Health, Bethesda, Maryland, and by grant IM-432 from the American Cancer Society.
Rights and permissions
About this article
Cite this article
Ginsburg, I., Fligiel, S.E.G., Ward, P.A. et al. Lipoteichoic acid-antilipoteichoic acid complexes induce superoxide generation by human neutrophils. Inflammation 12, 525–548 (1988). https://doi.org/10.1007/BF00914316
Issue Date:
DOI: https://doi.org/10.1007/BF00914316